Trial Profile
A Randomized, Single-center, Double-blind, 2-period Crossover, Euglycemic Glucose Clamp Study in Healthy Subjects to Demonstrate PK and PD Equivalence of Julphar Insulin R and Huminsulin Normal
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Gulf Pharmaceutical Industries
- 24 Dec 2015 New trial record